VERTICURE GB 8/16 is indicated for the management of vertigo and Meniere’s disease. It improves blood flow in the inner ear and helps reduce dizziness.
The formulation effectively controls tinnitus, nausea, and balance disorders, providing long-term symptom relief with good tolerability.
Suitable for chronic vestibular conditions, VERTICURE GB 8/16 supports improved stability and quality of life under medical guidance.
Better improvement in tinnitus volume and intensity. Reduces overall tinnitus severity. Improves balance and reduces dizziness.
Better improvement in tinnitus volume and intensity.
Reduces overall tinnitus severity.
Improves balance and reduces dizziness.
Betahistine is more effective than placebo or flunarizine in vertigo-related conditions. Helps improve inner ear microcirculation and vestibular function.
Improves quality of life in patients with vestibular disorders.